JPH0463852B2 - - Google Patents
Info
- Publication number
- JPH0463852B2 JPH0463852B2 JP16997083A JP16997083A JPH0463852B2 JP H0463852 B2 JPH0463852 B2 JP H0463852B2 JP 16997083 A JP16997083 A JP 16997083A JP 16997083 A JP16997083 A JP 16997083A JP H0463852 B2 JPH0463852 B2 JP H0463852B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- clotrimazole
- gel
- use according
- gel composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims description 28
- 229960004022 clotrimazole Drugs 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 claims description 8
- 229940031578 diisopropyl adipate Drugs 0.000 claims description 8
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 239000003349 gelling agent Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 claims description 5
- 229940043276 diisopropanolamine Drugs 0.000 claims description 5
- 230000003472 neutralizing effect Effects 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- 150000002334 glycols Chemical class 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical group OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 2
- 229940043237 diethanolamine Drugs 0.000 claims description 2
- 229940031098 ethanolamine Drugs 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- XMYQHJDBLRZMLW-UHFFFAOYSA-N methanolamine Chemical compound NCO XMYQHJDBLRZMLW-UHFFFAOYSA-N 0.000 claims description 2
- 229940087646 methanolamine Drugs 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229960004418 trolamine Drugs 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 239000000499 gel Substances 0.000 description 27
- 238000002360 preparation method Methods 0.000 description 14
- 238000009472 formulation Methods 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000008213 purified water Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000000003 vaginal tablet Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16997083A JPS6061518A (ja) | 1983-09-14 | 1983-09-14 | ゲル状外用組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16997083A JPS6061518A (ja) | 1983-09-14 | 1983-09-14 | ゲル状外用組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6061518A JPS6061518A (ja) | 1985-04-09 |
| JPH0463852B2 true JPH0463852B2 (xx) | 1992-10-13 |
Family
ID=15896184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16997083A Granted JPS6061518A (ja) | 1983-09-14 | 1983-09-14 | ゲル状外用組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6061518A (xx) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61151117A (ja) * | 1984-12-25 | 1986-07-09 | Bayer Yakuhin Kk | 抗真菌ゲル製剤 |
| JPS61252247A (ja) * | 1985-05-02 | 1986-11-10 | Mitsubishi Acetate Co Ltd | 透明なゲル組成物 |
| JPS61252246A (ja) * | 1985-05-02 | 1986-11-10 | Mitsubishi Acetate Co Ltd | 透明なゲル組成物 |
| JPS61257920A (ja) * | 1985-05-13 | 1986-11-15 | Sato Seiyaku Kk | 抗真菌外用ゲル剤 |
| US5288486A (en) * | 1985-10-28 | 1994-02-22 | Calgon Corporation | Alcohol-based antimicrobial compositions |
| US5002938A (en) * | 1988-03-21 | 1991-03-26 | Bristol-Myers Squibb Company | Antifungal gel formulations |
| US5110809A (en) * | 1988-03-21 | 1992-05-05 | Bristol-Myers Squibb Company | Antifungal gel formulations |
| JPH0725675B2 (ja) * | 1989-05-08 | 1995-03-22 | ホーユー株式会社 | 液状真菌症治療剤 |
| DE4337945A1 (de) * | 1993-11-06 | 1995-05-11 | Labtec Gmbh | Pflaster zur Behandlung von Nagelmykosen |
| JP3081766B2 (ja) * | 1994-05-06 | 2000-08-28 | 東興薬品工業株式会社 | 角質貯留型抗真菌外用組成物 |
| KR100342945B1 (ko) * | 1999-03-09 | 2002-07-02 | 민경윤 | 항진균제의 외용 약제 조성물 및 이의 제조방법 |
| US6899897B2 (en) | 2001-06-18 | 2005-05-31 | Jaleva, Inc. | Gum resin as a carrier for topical application of pharmacologically active agents |
| KR100511114B1 (ko) * | 2002-07-16 | 2005-08-31 | 우원홍 | 항진균제를 함유한 피부 미백용 외용제 조성물 및 이를포함하는 미백용 외용제 |
| US9554984B2 (en) | 2003-11-03 | 2017-01-31 | Jaleva Pharmaceuticals, Llc | Oral care compositions for topical application |
| CA2629810A1 (en) | 2005-11-07 | 2007-05-18 | Jaleva, Llc | Film-forming resins as a carrier for topical application of pharmacologically active agents |
| US8889155B2 (en) | 2006-12-28 | 2014-11-18 | Kaken Pharmaceutical Co., Ltd. | Gel composition for treating mycosis |
| JP2011173823A (ja) * | 2010-02-24 | 2011-09-08 | Hisamitsu Pharmaceut Co Inc | ゲル製剤 |
-
1983
- 1983-09-14 JP JP16997083A patent/JPS6061518A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6061518A (ja) | 1985-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0463852B2 (xx) | ||
| US6239177B1 (en) | Tranilast-containing preparation for external application and method of producing the same | |
| JP3081766B2 (ja) | 角質貯留型抗真菌外用組成物 | |
| US4552872A (en) | Penetrating topical pharmaceutical compositions containing corticosteroids | |
| US4678666A (en) | Topical anti-inflammatory compositions | |
| US20100292199A1 (en) | Transcutaneous pharmaceutical compositions containing a steroid hormone | |
| JPS6135166B2 (xx) | ||
| JP2555555B2 (ja) | 抗真菌性外用製剤 | |
| JPH07223971A (ja) | 皮膚外用剤 | |
| JP2001513093A (ja) | 局所用ニムスリドゲルシステム | |
| KR20020069378A (ko) | 항진균 외용 제제 | |
| JPH07557B2 (ja) | 皮膚炎に対する治療用組成物 | |
| JPS6218526B2 (xx) | ||
| US5817675A (en) | Compositions for the treatment of psoriasis and their use | |
| KR20020038595A (ko) | 피부 침투제를 포함하는 국소용 제제 및 그의 용도 | |
| US4602040A (en) | Meclofenamic acid topical pharmaceutical composition | |
| JPH0481569B2 (xx) | ||
| JPS58172312A (ja) | ニフエジピン外用剤 | |
| JP2002356430A (ja) | 吉草酸酢酸プレドニゾロン及び抗ヒスタミン剤を含む皮膚外用剤 | |
| JPH0231052B2 (xx) | ||
| CA2515259C (en) | Use of acetylsalicylic acid for the treatment of hemorrhoidal disease | |
| EP2340016B1 (en) | Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate | |
| JPH0242812B2 (xx) | ||
| CA2244679C (en) | Tranilast-containing preparation for external application and method of producing the same | |
| JPH01102024A (ja) | 外用皮膚疾患治療剤 |